SBIR/STTR Research Award
Excitation Enhanced Ultrasound Contrast Imaging
Award amount
$305,099Program and phase
SBIR · Phase IIAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SPECTRASONICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Provided by Applicant): This project proposes the development of a
new technique for improving the performance of medical ultrasound systems using
microbubble-based contrast agents. The ultimate goal is the creation of an
"excitation enhanced" imaging system that will have a higher sensitivity than
current ultrasound scanners. Vascular contrast agents are capable of enhancing
the visibility of blood flow by several orders of magnitude. However their
performance is still not sufficient to reliably image perfusion and diagnose
conditions such as myocardial ischemia or infarction. The excitation enhanced
ultrasound modality utilizes two acoustic fields: onefor contrast agent
excitation and one for imaging. The excitation field temporarily increases the
number of contrast agent bubbles with a size close to resonance at the
frequency of the imaging field. If the imaging field is applied immediately
after the excitation burst, acoustic scattering from the excited bubbles is
markedly stronger than without the application of the excitation field. An in
vitro system was constructed as part of the Phase I effort and experiments
conducted using this system have demonstrated enhancements of up to 12dB. The
next step is to modify an ultrasound scanner to include the modality and to
validate the clinical potential of the technique with a series of in vivo
experiments.
PROPOSED COMMERCIAL APPLICATION:
Ultrasonic Imaging is now the second most widely used imaging modality after x-ray. It's usage has increased in recent years due to the development of ultrasonic specific contrast agents. The proposed research will accelerate the usefulness of contrast aganets for many significant clinical applications.
Technology keywords
Not reported